(NASDAQ: PETS) Petmed Express's forecast annual revenue growth rate of 3.52% is not forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 32.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 56.88%.
Petmed Express's revenue in 2026 is $194,994,000.On average, 3 Wall Street analysts forecast PETS's revenue for 2026 to be $4,338,867,544, with the lowest PETS revenue forecast at $4,168,766,157, and the highest PETS revenue forecast at $4,466,443,584. On average, 3 Wall Street analysts forecast PETS's revenue for 2027 to be $4,468,153,146, with the lowest PETS revenue forecast at $4,292,923,074, and the highest PETS revenue forecast at $4,599,575,700.
In 2028, PETS is forecast to generate $4,590,386,806 in revenue, with the lowest revenue forecast at $4,410,241,744 and the highest revenue forecast at $4,725,228,484.